BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23559629)

  • 1. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.
    Zhang H; Taylor WR; Joseph G; Caracciolo V; Gonzales DM; Sidell N; Seli E; Blackshear PJ; Kallen CB
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1212-20. PubMed ID: 23559629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.
    Makita S; Takatori H; Nakajima H
    Front Immunol; 2021; 12():711633. PubMed ID: 34276705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
    Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mRNA-binding protein Zfp36 is upregulated by β-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes.
    Brahma PK; Zhang H; Murray BS; Shu FJ; Sidell N; Seli E; Kallen CB
    Obesity (Silver Spring); 2012 Jan; 20(1):40-7. PubMed ID: 21818148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
    Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation.
    Hahn RT; Hoppstädter J; Hirschfelder K; Hachenthal N; Diesel B; Kessler SM; Huwer H; Kiemer AK
    Atherosclerosis; 2014 Jun; 234(2):391-400. PubMed ID: 24747114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS.
    Shah S; Mostafa MM; McWhae A; Traves SL; Newton R
    J Biol Chem; 2016 Jan; 291(1):110-25. PubMed ID: 26546680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection.
    Hyatt LD; Wasserman GA; Rah YJ; Matsuura KY; Coleman FT; Hilliard KL; Pepper-Cunningham ZA; Ieong M; Stumpo DJ; Blackshear PJ; Quinton LJ; Mizgerd JP; Jones MR
    PLoS One; 2014; 9(10):e109072. PubMed ID: 25299049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Bax pathway.
    Cao Y; Huang W; Wu F; Shang J; Ping F; Wang W; Li Y; Zhao X; Zhang X
    Cell Death Dis; 2021 Jul; 12(7):685. PubMed ID: 34238924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.
    Tian L; Luo N; Zhu X; Chung BH; Garvey WT; Fu Y
    Atherosclerosis; 2012 Mar; 221(1):66-75. PubMed ID: 22227293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses.
    Cook ME; Bradstreet TR; Webber AM; Kim J; Santeford A; Harris KM; Murphy MK; Tran J; Abdalla NM; Schwarzkopf EA; Greco SC; Halabi CM; Apte RS; Blackshear PJ; Edelson BT
    Sci Immunol; 2022 Oct; 7(76):eabo0981. PubMed ID: 36269839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZFP36 promotes VDR mRNA degradation to facilitate cell death in oral and colonic epithelial cells.
    Wang X; Ge X; Liao W; Cao Y; Li R; Zhang F; Zhao B; Du J
    Cell Commun Signal; 2021 Aug; 19(1):85. PubMed ID: 34380509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global target mRNA specification and regulation by the RNA-binding protein ZFP36.
    Mukherjee N; Jacobs NC; Hafner M; Kennington EA; Nusbaum JD; Tuschl T; Blackshear PJ; Ohler U
    Genome Biol; 2014 Jan; 15(1):R12. PubMed ID: 24401661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.
    Moore MJ; Blachere NE; Fak JJ; Park CY; Sawicka K; Parveen S; Zucker-Scharff I; Moltedo B; Rudensky AY; Darnell RB
    Elife; 2018 May; 7():. PubMed ID: 29848443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.
    Jin WJ; Chen CF; Liao HY; Gong LL; Yuan XH; Zhao BB; Zhang D; Feng X; Liu JJ; Wang Y; Chen GF; Yan HP; He YW
    PLoS One; 2012; 7(3):e33356. PubMed ID: 22428029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation.
    Angiolilli C; Kabala PA; Grabiec AM; Rossato M; Lai WS; Fossati G; Mascagni P; Steinkühler C; Blackshear PJ; Reedquist KA; Baeten DL; Radstake TRDJ
    Arthritis Res Ther; 2018 Jul; 20(1):148. PubMed ID: 30029685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.